Clinical trial: five or ten cycles of granulocyte-monocyte apheresis (GMA) show equivalent efficacy and safety in ulcerative colitis

A U Dignass ¹, A Eriksson, A Kilander, A Pukitis, J M Rhodes, S Vavricka, Aliment Pharmacol Ther. 2010 Jun;31(12):1286-95.

This prospective study comparing apheresis regimens in ulcerative colitis demonstrates that 5 treatments were not inferior to 10 treatments in steroid-refractory or -dependent ulcerative colitis.

https://pubmed.ncbi.nlm.nih.gov/20331579/

https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2036.2010.04295.x